25254000: Procainamide hydrochloride (substance)

SNOMED CT Concept\Substance\...

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Cardiovascular agent (substance)\Antiarrhythmic agent (substance)\Class I antiarrhythmic agent (substance)\Class Ia antiarrhythmic agent (substance)\Procainamide hydrochloride

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Substance with benzamide structure\Procainamide hydrochloride

\Organic compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Substance with benzamide structure\Procainamide hydrochloride

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Procainamide hydrochloride	Is a	Product containing procainamide (medicinal product)	false	Inferred relationship	Some
Procainamide hydrochloride	Is a	Procainamide (substance)	false	Inferred relationship	Some
Procainamide hydrochloride	Is a	Drug allergen by structure	false	Inferred relationship	Some
Procainamide hydrochloride	Is a	Class Ia antiarrhythmic agent (substance)	true	Inferred relationship	Some
Procainamide hydrochloride	Is a	Benzamide (substance)	false	Inferred relationship	Some
Procainamide hydrochloride	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	Procainamide (substance)	true	Inferred relationship	Some
Procainamide hydrochloride	Is a	Substance with benzamide structure	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
procainamidhydrochlorid 100 mg/ml injektionsvæske, opløsning, ampul a 10 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Procainamide hydrochloride	Inferred relationship	Some
Procainamide hydrochloride 250 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Procainamide hydrochloride	Inferred relationship	Some
Procainamide hydrochloride 375 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Procainamide hydrochloride	Inferred relationship	Some
Procainamide hydrochloride 500 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Procainamide hydrochloride	Inferred relationship	Some
Product containing precisely procainamide hydrochloride 500 milligram/1 each conventional release oral capsule (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Procainamide hydrochloride	Inferred relationship	Some
Procainamide hydrochloride 250 mg oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Procainamide hydrochloride	Inferred relationship	Some
procainamidhydrochlorid 1000 mg tablet med modificeret udløsning	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Procainamide hydrochloride	Inferred relationship	Some
procainamidhydrochlorid 500 mg tablet med modificeret udløsning	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Procainamide hydrochloride	Inferred relationship	Some
procainamidhydrochlorid 250 mg tablet med modificeret udløsning	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Procainamide hydrochloride	Inferred relationship	Some
procainamidhydrochlorid 750 mg tablet med modificeret udløsning	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Procainamide hydrochloride	Inferred relationship	Some
Product containing precisely procainamide hydrochloride 375 milligram/1 each conventional release oral capsule (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Procainamide hydrochloride	Inferred relationship	Some
procainamidhydrochlorid 500 mg/ml injektionsvæske	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Procainamide hydrochloride	Inferred relationship	Some
Procainamide hydrochloride 250 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Procainamide hydrochloride	Inferred relationship	Some	1
Procainamide hydrochloride 250 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Procainamide hydrochloride	Inferred relationship	Some	1
Procainamide hydrochloride 375 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Procainamide hydrochloride	Inferred relationship	Some	1
Procainamide hydrochloride 375 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Procainamide hydrochloride	Inferred relationship	Some	1
Procainamide hydrochloride 500 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Procainamide hydrochloride	Inferred relationship	Some	1
Procainamide hydrochloride 500 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Procainamide hydrochloride	Inferred relationship	Some	1
Product containing precisely procainamide hydrochloride 500 milligram/1 each conventional release oral capsule (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Procainamide hydrochloride	Inferred relationship	Some	1
Product containing precisely procainamide hydrochloride 500 milligram/1 each conventional release oral capsule (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Procainamide hydrochloride	Inferred relationship	Some	1
Procainamide hydrochloride 250 mg oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Procainamide hydrochloride	Inferred relationship	Some	1
Procainamide hydrochloride 250 mg oral capsule	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Procainamide hydrochloride	Inferred relationship	Some	1
Product containing precisely procainamide hydrochloride 375 milligram/1 each conventional release oral capsule (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Procainamide hydrochloride	Inferred relationship	Some	1
Product containing precisely procainamide hydrochloride 375 milligram/1 each conventional release oral capsule (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Procainamide hydrochloride	Inferred relationship	Some	1
Procainamide hydrochloride 750mg prolonged-release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Procainamide hydrochloride	Inferred relationship	Some
Procainamide hydrochloride 250mg prolonged-release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Procainamide hydrochloride	Inferred relationship	Some
Procainamide hydrochloride 500 mg prolonged-release oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Procainamide hydrochloride	Inferred relationship	Some	1
Procainamide hydrochloride 500 mg prolonged-release oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Procainamide hydrochloride	Inferred relationship	Some	1
Product containing precisely procainamide hydrochloride 1 gram/1 each prolonged-release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Procainamide hydrochloride	Inferred relationship	Some	1
Product containing precisely procainamide hydrochloride 1 gram/1 each prolonged-release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Procainamide hydrochloride	Inferred relationship	Some	1
Procainamide hydrochloride 250 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Procainamide hydrochloride	Inferred relationship	Some	1
Procainamide hydrochloride 500 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Procainamide hydrochloride	Inferred relationship	Some	1
Product containing precisely procainamide hydrochloride 500 milligram/1 each conventional release oral capsule (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Procainamide hydrochloride	Inferred relationship	Some	1
Procainamide hydrochloride 250 mg oral capsule	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Procainamide hydrochloride	Inferred relationship	Some	1
Product containing precisely procainamide hydrochloride 375 milligram/1 each conventional release oral capsule (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Procainamide hydrochloride	Inferred relationship	Some	1
Procainamide hydrochloride 375 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Procainamide hydrochloride	Inferred relationship	Some	1

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
42334019	Procainamide hydrochloride	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
42335018	Procaine amide hydrochloride	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
755550017	Procainamide hydrochloride (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
2657801000005117	Procainamidhydrochlorid	da	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	Danish module (core metadata concept)